Vanderbilt Therapeutics (VT) CRS

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• HIV5 trials
• Depression1 trial
• Hepatitis B1 trial

Phase

• Phase 22 trials
• Phase 32 trials
• Phase 11 trial

Status

• Completed2 trials
• Suspended2 trials
• Terminated1 trial

Lead sponsor

• National Institute of Allergy and Infectious Diseases (NIAID)5 trials

Closed trials

• Terminated

  A Study to Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive Antiretroviral Therapy, Plus Its Effect on Chronic Inflammation, HIV Persistence and Other Clinical Outcomes.

  NCT04840199· Phase 2· National Institute of Allergy and Infectious Diseases (NIAID)· Source

• Completed

  B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B

  NCT04193189· Phase 3· National Institute of Allergy and Infectious Diseases (NIAID)· Source

• Completed

  The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE

  NCT03635788· Phase 3· National Institute of Allergy and Infectious Diseases (NIAID)· Source